Cigna sets November 5 results date. Cigna Group stock sits 2.39 percent below its high

The Cigna Group (ISIN US1255231003) will release its third-quarter 2026 results on November 5, 2026, with the announcement scheduled before the market opens, MarketScreener reported on October 9, 2026. The date gives investors a defined checkpoint for the health services company's next operating update.

At Lang & Schwarz, the stock was trading at EUR 275.25 on October 26, 2026 at 4:07 p.m. CEST, up 0.29 percent versus the Xetra close of October 23, 2026 at EUR 274.45.

Financial targets remain in place

At its September 30, 2026 Investor Day, The Cigna Group reaffirmed 2026 adjusted revenue of USD 280.00 billion and adjusted earnings per share of at least USD 30.45. The company also set a 10.00 percent to 14.00 percent adjusted earnings-per-share compound annual growth target through 2030, according to PR Newswire.

Stock stays below its yearly high

The EUR 275.25 quote is 2.39 percent below the EUR 282.00 52-week high and remains EUR 66.85 above the EUR 208.40 low. The primary listing is on the NYSE, where Cigna's stock last traded at USD 306.95 on October 23, 2026. The euro quotation therefore gives German investors a separate trading perspective from the US closing level.

Valuation and dates ahead

Cigna Group's market capitalization was USD 72.70 billion and its price-to-earnings ratio was 12.81 as of October 26, 2026. The third-quarter results are due on November 5, 2026, no later than 6:30 a.m. ET, followed by the conference call at 8:30 a.m. ET. The company also said board member Donna F. Zarcone will retire effective December 31, 2026, MarketScreener listed on October 9, 2026.

Comparison with peers

Cigna Group: up 0.29 percent versus the Xetra close, P/E 12.81, market capitalization USD 72.70 billion.

Elevance Health (NYSE, USD): down 1.51 percent, P/E 18.49, market capitalization USD 94.00 billion.

Humana (NYSE, USD): down 0.01 percent, P/E 40.01, market capitalization USD 50.70 billion.

What the November date means

The November 5 release will test whether the company's first-half performance supports the full-year adjusted earnings target of at least USD 30.45. For investors, the revenue scale and earnings trajectory will matter more than the small euro move on October 26.

The stock was trading at EUR 275.25 at Lang & Schwarz on October 26, 2026 at 4:07 p.m. CEST, 0.29 percent above the Xetra close of October 23, 2026 at EUR 274.45. The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.

Market context: Market report S&P 500.

More news and analyses on Cigna Group stock